45 Medical Leaders Share How Medical Affairs Can Increase RWE Creation and Utilization

CHAPEL HILL, N.C., Jun. 25, 2020/PRNewswire/ -- The demand for real world evidence (RWE) has skyrocketed among key stakeholders across the entire healthcare value chain: thought leaders, providers, payers, and regulatory bodies.

In response, pharmaceutical and medical device companies are taking rapid steps to increase their RWE capabilities, in particular the role of Medical Affairs. Medical plays an essential role in the landscape of RWE activities that include RWE strategic decision making, oversight, evaluating evidence gaps, and interpreting the medical and clinical value of health outcomes.

To inform medical leadership's decision-making on RWE, Best Practices, LLC conducted a study to evaluate the role of Medical Affairs in real world evidence; the study found that medical teams involved with RWE-based activities require sub-functional diversity for top performance with strategy, clinical and publications among the sub-functions participants cited as best for working with RWE medical teams.

Topics addressed in "How Strong Medical Affairs Teams Use RWE to Achieve Impact along Patient, Disease State, Clinical and Payer Fronts" include:

• Real World Evidence in 2020 and Beyond
• Real World Data – Collection & the Total Data Packaged
• Medical Affairs Teams, Roles, & Responsibilities
• Real World Data Utilization & Evidence Generation
• Real World Evidence Investment
• KPIs and Measuring Organizational RWE Performance

Best Practices engaged 45 industry leaders across 36 companies to discern RWD/E best practices, trends, and Medical Affairs optimal role. This study will help Medical Affairs leaders regarding the current trends and practices of medical regarding real world data collection and RWE issues such as responsibilities, utilization, investment and ROI.

To learn more about this report, download a complimentary report excerpt at https://www.best-in-class.com/rw109.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.